Publications by authors named "Jacob Bleesing"

Claim this Profile
P
Posttransplantation late complications increase over time for patients with SCID: A Primary Immune Deficiency Treatment Consortium (PIDTC) landmark study.
Hesham Eissa, Monica S Thakar, Ami J Shah, Brent R Logan, Linda M Griffith, Jacob H Bleesing

J Allergy Clin Immunol· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Ruxolitinib for the Treatment of Chronic GVHD and Overlap Syndrome in Children and Young Adults.
YunZu Michele Wang, Ashley Teusink-Cross, Yasser Elborai, M Christa Krupski, Adam S Nelson, Jacob J Bleesing

Transplantation· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
International retrospective study of allogeneic hematopoietic cell transplantation for activated PI3K-delta syndrome.
Dimana Dimitrova, Zohreh Nademi, Maria Elena Maccari, Stephan Ehl, Gulbu Uzel, Jacob J Bleesing

J Allergy Clin Immunol· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Daratumumab for the management of autoimmune cytopenias in children and young adults: a case series.
Pooja Khandelwal, Ashley Teusink-Cross, Ashish R Kumar, Jacob J Bleesing, Parinda A Mehta

Br J Haematol· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Four Biomarkers Linked to Activation of Cluster of Differentiation 8-Positive Lymphocytes Predict Clinical Outcomes in Pediatric Acute Liver Failure.
Mike A Leonis, Alexander G Miethke, Lin Fei, Sean Maynor, Catherine A Chapin, Jacob J H Bleesing

Hepatology· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CCR5 inhibitor as novel acute graft versus host disease prophylaxis in children and young adults undergoing allogeneic stem cell transplant: results of the phase II study.
Pooja Khandelwal, Tsuyoshi Fukuda, Ashley Teusink-Cross, Angela D M Kashuba, Adam Lane, Jacob J Bleesing

Bone Marrow Transplant· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Successful liver transplantation in short telomere syndromes without bone marrow failure due to DKC1 mutation.
Rodrigo Del Brío Castillo, Jacob Bleesing, Thomas McCormick, James E Squires, George V Mazariegos

Pediatr Transplant· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Partial RAG deficiency in a patient with varicella infection, autoimmune cytopenia, and anticytokine antibodies.
Vera Goda, Aniko Malik, Tibor Kalmar, Zoltan Maroti, Bhumika Patel, Jacob Bleesing

J Allergy Clin Immunol Pract· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Successful Bone Marrow Transplantation for XMEN: Hemorrhagic Risk Uncovered.
Dimana Dimitrova, Jeremy J Rose, Gulbu Uzel, Jeffrey I Cohen, Koneti V Rao, Jacob H Bleesing

J Clin Immunol· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hypogammaglobulinemia with decreased class-switched B-cells and dysregulated T-follicular-helper cells in IPEX syndrome.
Oded Shamriz, Kiran Patel, Rebecca A Marsh, Jacob Bleesing, Avni Y Joshi

Clin Immunol· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impaired immune function in children and adults with Fanconi anemia.
Kasiani C Myers, Sharon Sauter, Xue Zhang, Jacob J Bleesing, Stella M Davies

Pediatr Blood Cancer· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum: Natural Killer Cells from Patients with Recombinase-Activating Gene and Non-Homologous End Joining Gene Defects Comprise a Higher Frequency of CD56 NKG2A Cells, and Yet Display Increased Degranulation and Higher Perforin Content.
Kerry Dobbs, Giovanna Tabellini, Enrica Calzoni, Ornella Patrizi, Paula Martinez, Jacob Bleesing

Front Immunol· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Natural Killer Cells from Patients with Recombinase-Activating Gene and Non-Homologous End Joining Gene Defects Comprise a Higher Frequency of CD56 NKG2A Cells, and Yet Display Increased Degranulation and Higher Perforin Content.
Kerry Dobbs, Giovanna Tabellini, Enrica Calzoni, Ornella Patrizi, Paula Martinez, Jacob Bleesing

Front Immunol· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Prospective Study of Alemtuzumab as a Second-Line Agent for Steroid-Refractory Acute Graft-versus-Host Disease in Pediatric and Young Adult Allogeneic Hematopoietic Stem Cell Transplantation.
Pooja Khandelwal, Chie Emoto, Tsuyoshi Fukuda, Alexander A Vinks, Lisa Neumeier, Jacob J Bleesing

Biol Blood Marrow Transplant· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of T and B cell repertoire diversity in patients with RAG deficiency.
Yu Nee Lee, Francesco Frugoni, Kerry Dobbs, Irit Tirosh, Likun Du, Jacob H Bleesing

Sci Immunol· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Single-Center Experience Comparing Alemtuzumab, Fludarabine, and Melphalan Reduced-Intensity Conditioning with Myeloablative Busulfan, Cyclophosphamide, and Antithymocyte Globulin for Chronic Granulomatous Disease.
Pooja Khandelwal, Jacob J Bleesing, Stella M Davies, Rebecca A Marsh

Biol Blood Marrow Transplant· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of outcomes of hematopoietic stem cell transplantation without chemotherapy conditioning by using matched sibling and unrelated donors for treatment of severe combined immunodeficiency.
Christopher C Dvorak, Amel Hassan, Mary A Slatter, Manfred Hönig, Arjan C Lankester, Jacob H Bleesing

J Allergy Clin Immunol· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The successful use of alemtuzumab for treatment of steroid-refractory acute graft-versus-host disease in pediatric patients.
Pooja Khandelwal, Julia Lawrence, Alexandra H Filipovich, Stella M Davies, Jacob J Bleesing

Pediatr Transplant· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis